Delivery Order SPE2DR25D2010-SPE2DR26F4ZKR
- Not listed
- The Defense Logistics Agency awarded a $3,437.98 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a subcutaneous auto-injector medication used to treat rheumatoid arthritis, Crohn's disease, and other autoimmune conditions. The contract, awarded on May 30, 2025, with an ultimate completion date of June 2, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $20,650.18 to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 mg/0.4 mls, a rheumatoid arthritis and autoimmune disease treatment. The contract, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,063.60 on September 3, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, an injectable rheumatoid arthritis and autoimmune disease treatment. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single-item pharmaceutical procurement with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,886.97 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name rheumatoid arthritis and immunological disease treatment. This firm fixed-price, competitively awarded delivery order was executed on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescribed injectable medication used to treat rheumatoid arthritis and other inflammatory conditions. This competitively awarded, non-set-aside delivery order carries a ceiling value of $7,470.37 under firm fixed price terms, with an ultimate completion date of December 9, 2025. The order will be fulfilled from AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order valued at $17,041.94 to AmerisourceBergen Drug Corp for the supply of HUMIRA Pen 40 mg/0.8 mL on December 11, 2025, with an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. HUMIRA is a widely-used biologic immunosuppressant medication primarily indicated for...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and was awarded on June 16, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,959.80 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a rheumatoid arthritis and autoimmune disease treatment. This firm fixed-price, non-set-aside contract was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a single task issued under a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,542.07 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. HUMIRA is a leading biologic immunosuppressant medication used to treat various...
- The Defense Logistics Agency awarded a delivery order valued at $6,767.70 to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 mg/0.4 mL, a rheumatoid arthritis and autoimmune disease medication. This firm fixed-price delivery order was competitively awarded without set-aside status on December 4, 2025, with an ultimate completion date of December 5, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child contract issued...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZKRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,353.26 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a subcutaneous injection used to treat autoimmune conditions including rheumatoid arthritis, psoriasis, and Crohn's disease. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 23, 2025, and was awarded on December 22, 2025. The delivery order is being fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. As a child contract under this IDC vehicle, this delivery order represents one of numerous pharmaceutical procurements the contractor fulfills to support military healthcare systems and the Defense Health Agency. AmerisourceBergen's substantial IDC and consistent history of competitively awarded federal pharmaceutical contracts demonstrate the company's established capacity to serve as a critical vendor for federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.4k | 12/21/25 |